The burden of selected digestive diseases in the United States.

By R. Sandler, J. Everhart, M. Donowitz, Elizabeth Adams, K. Cronin, C. Goodman, E. Gemmen, Shefali Shah, Aida Avdić, R. Rubin. Gastroenterology, 2002

1,562 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/52ac9227209f936d2f93bc3595b38c1d6a65568b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. L. Stinton
2. Bruno Bonaz
3. E. Shaffer
4. A. Mulak
5. B. Toner
6. M. Schmulson
7. N. Shaheen
8. A. Sperber

Citations in the corpus

• Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer (2012, background): “, constituting a major health burden that has increased more than 20% over the last 3 decades.(2,8,9) With an estimated 1.”
• Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. (2020, background): “per year for any health problems, and (2) quality o f life scores on the PROMIS Global-10”
• Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. (2003, methodology): “Finally, exploratory subanalyses were performed to assess differential responses to treatment with the following pretreatment variables: (1) moderate (FBDSI, 110) and severe (FBDSI, 110) symptoms, (2) abuse history and no abuse history, (3) depressive symptoms (BDI, 16) and no depressive symptoms (B”
• The Burden of Gastrointestinal and Liver Diseases, 2006 (2006, background): “In excess of 40 billion dollars of health-care expenditures are used for gastrointestinal diseases annually (2).”